Group One Trading’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-11,950
| Closed | -$143K | – | 8917 |
|
|
2025
Q2 | $111K | Buy |
11,950
+5,212
| +77% | +$40.8K | ﹤0.01% | 4883 |
|
|
2025
Q1 | $49.4K | Sell |
6,738
-3,198
| -32% | -$24.6K | ﹤0.01% | 5171 |
|
|
2024
Q4 | $84.9K | Sell |
9,936
-18,497
| -65% | -$180K | ﹤0.01% | 4650 |
|
|
2024
Q3 | $247K | Sell |
28,433
-12,292
| -30% | -$101K | ﹤0.01% | 3427 |
|
|
2024
Q2 | $279K | Sell |
40,725
-332,578
| -89% | -$2.05M | ﹤0.01% | 3109 |
|
|
2024
Q1 | $3.4M | Buy |
373,303
+328,904
| +741% | +$2.33M | 0.01% | 1103 |
|
|
2023
Q4 | $198K | Buy |
44,399
+36,119
| +436% | +$107K | ﹤0.01% | 3870 |
|
|
2023
Q3 | $26K | Buy |
+8,280
| New | +$33.9K | ﹤0.01% | 5663 |
|
|
2023
Q2 | – | Sell |
-39,742
| Closed | -$236K | – | 8033 |
|
|
2023
Q1 | $209K | Buy |
39,742
+17,750
| +81% | +$84.3K | ﹤0.01% | 3623 |
|
|
2022
Q4 | $61.8K | Sell |
21,992
-15,697
| -42% | -$52K | ﹤0.01% | 4839 |
|
|
2022
Q3 | $156K | Buy |
37,689
+25,719
| +215% | +$130K | ﹤0.01% | 4376 |
|
|
2022
Q2 | $48K | Buy |
11,970
+10,912
| +1,031% | +$41.2K | ﹤0.01% | 5587 |
|
|
2022
Q1 | $5K | Buy |
+1,058
| New | +$5.86K | ﹤0.01% | 7468 |
|
|
2021
Q4 | – | Sell |
-42,495
| Closed | -$330K | – | 8658 |
|
|
2021
Q3 | $425K | Sell |
42,495
-40,232
| -49% | -$452K | ﹤0.01% | 4377 |
|
|
2021
Q2 | $1.17M | Buy |
82,727
+32,052
| +63% | +$487K | ﹤0.01% | 3227 |
|
|
2021
Q1 | $832K | Sell |
50,675
-12,756
| -20% | -$246K | ﹤0.01% | 3440 |
|
|
2020
Q4 | $1.31M | Buy |
63,431
+47,408
| +296% | +$704K | ﹤0.01% | 2404 |
|
|
2020
Q3 | $122K | Buy |
+16,023
| New | +$133K | ﹤0.01% | 4049 |
|
|
2019
Q4 | – | Sell |
-4,907
| Closed | -$17.1K | – | 5467 |
|
|
2019
Q3 | $15K | Buy |
+4,907
| New | +$21.9K | ﹤0.01% | 4463 |
|
|
2019
Q1 | – | Sell |
-10,827
| Closed | -$43.5K | – | 5202 |
|
|
2018
Q4 | $43K | Sell |
10,827
-6,745
| -38% | -$37.2K | ﹤0.01% | 3637 |
|
|
2018
Q3 | $121K | Buy |
+17,572
| New | +$110K | ﹤0.01% | 3393 |
|
|
2018
Q1 | – | Sell |
-4,684
| Closed | -$26.4K | – | 5180 |
|
|
2017
Q4 | $21K | Sell |
4,684
-170
| -4% | -$868 | ﹤0.01% | 4134 |
|
|
2017
Q3 | $30K | Buy |
+4,854
| New | +$31.3K | ﹤0.01% | 3884 |
|
|
2017
Q2 | – | Sell |
-5,160
| Closed | -$49.9K | – | 4972 |
|
|
2017
Q1 | $48K | Buy |
5,160
+955
| +23% | +$7.95K | ﹤0.01% | 3435 |
|
|
2016
Q4 | $35K | Sell |
4,205
-2,537
| -38% | -$19.7K | ﹤0.01% | 3457 |
|
|
2016
Q3 | $46K | Buy |
+6,742
| New | +$41.1K | ﹤0.01% | 3389 |
|
|
2015
Q4 | – | Sell |
-1,923
| Closed | -$20.8K | – | 4980 |
|
|
2015
Q3 | $27K | Buy |
+1,923
| New | +$38.6K | ﹤0.01% | 3898 |
|
Other funds holding OCUL
DTC
ACA
SR
VA
VCM
Group One Trading's OCUL Position: Q3 2025 in Review
Group One Trading sold out of Ocular Therapeutix (OCUL) in Q3 2025, closing a stake of 11,950 shares — an estimated $143K sold.
Group One Trading first reported a position in OCUL in Q3 2015 and held it in 27 quarters. The position peaked at $3.4M in Q1 2024. 216 funds tracked by Wall St. Rank hold OCUL as of Q3 2025.
- Group One Trading reported no remaining Ocular Therapeutix position as of Q3 2025 after selling out during the quarter.
- Group One Trading sold 11,950 Ocular Therapeutix shares in Q3 2025, an estimated $143K.
- Group One Trading first reported a position in Ocular Therapeutix in Q3 2015 and held it in 27 quarters.
- Group One Trading's Ocular Therapeutix position peaked at $3.4M in Q1 2024.
- 216 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2025.
Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.